期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | AMERICAN JOURNAL OF HEMATOLOGY LetPub Score 7.8
50 ratings
Rate
Reputation 8.8 Influence 6.7 Speed 9.2 | ||||||||||||||||
期刊簡稱 | AM J HEMATOL | ||||||||||||||||
ISSN | 0361-8609 | ||||||||||||||||
E-ISSN | 1096-8652 | ||||||||||||||||
h-index | 92 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 5.90%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1096-8652 | ||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/ajh | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Wiley-Liss Inc. | ||||||||||||||||
主題領域 | 医学 | ||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||
創刊年 | 1976 | ||||||||||||||||
每年文章數 | 174每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 29.12% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0361-8609%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-6 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Moderate | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 下一頁 末頁 (頁 | |
[AMERICAN JOURNAL OF HEMATOLOGY] 的評論 | 撰寫評論 |
作者: 白骨奇希 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-16 19:40:20 評論於 Three days.(0) 讚! | 白骨奇希 |
作者: 罗朝天 領域: 医学 審稿時間: 1.0 month(s) 結果: 直接被接受 撰寫評論 |
2024-07-22 19:42:46 評論於 Super fast, really fast.(0) 讚! | 罗朝天 |
作者: 巴蜀玮琪 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-22 12:12:12 評論於 How long does it take to receive a rejection notice?(0) 讚! | 巴蜀玮琪 |
作者: 蚀骨源源 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-27 15:27:36 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Emphasized research direction: Acute myeloid leukemia Experience sharing: Rejection is fast, good reviews(0) 讚! | 蚀骨源源 |
作者: 白云普涵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-08-30 21:43:54 評論於 Could you please translate the following paragraph into English and Japanese, and use ":" and ":" as titles?(0) 讚! | 白云普涵 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:57:22 評論於 Bar charts use the height of the bars to reflect differences in data, and the human eye is very sensitive to differences in height. Line charts are generally used to show trends, with the horizontal axis usually representing dates; they are able to reflect data trends easily(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:00:36 評論於 The three-line table is recommended for use in scientific papers due to its concise form and clear functionality, making it easy to read(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 22:17:31 評論於 Why do journals require the use of tables with three lines/What is the significance of using tables with three lines?(0) 讚! | 陶宜三岁啦 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 10:22:11 評論於 When to use a bar chart and when to use a line chart?(0) 讚! | Oswald Edie |
作者: 六阳庚戌 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-06-18 11:39:57 評論於 The submission was rejected after 3 weeks, with the reason being significant issues with the research design. It feels like it didn't reach the recommended reviewers, but it did go to experts in the relevant field who provided a lot of feedback. Overall, the submission and review process were very efficient, and I recommend everyone to give it a try(0) 讚! | 六阳庚戌 |
作者: Burgess Dobbin 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-26 17:51:47 評論於 Do you understand basic research?(0) 讚! | Burgess Dobbin |
作者: 六阳庚戌 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-19 15:28:10 評論於 Three days after submission, the status changed from Assigning Editor to Under Review. It has been Under Review for a week now, hoping for some good news(0) 讚! | 六阳庚戌 |
作者: 终幕紫蕙 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-14 20:58:35 評論於 Do you want to ask about catch net meta?(0) 讚! | 终幕紫蕙 |
作者: tianer 領域: 医学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2021-03-01 14:15:16 評論於 The reviewer's comments were responded to within one week of submission, and the revised version was accepted within one week. The editor was very responsible and efficient.(1) 讚! | tianer |
作者: Douglas Simon 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-14 13:23:20 評論於 What magazine is seeking contributions? yougre 2018-11-23 00:00:00 posted: The rejection efficiency is very high and does not waste time. The editor strongly recommends me to switch to another 3-point magazine. After switching, the layout fee will be discounted by 20%. I have already switched for 10 days, but I have not received any news yet. However, no news is the best news, right?(0) 讚! | Douglas Simon |
作者: 北国小江 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-14 20:46:30 評論於 Can CASE be invested in?(0) 讚! | 北国小江 |
作者: 熙恩mm 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-11-23 17:35:44 評論於 The rejection efficiency is very high, it doesn't waste time, and the editor strongly recommends me to submit to another 3-point magazine. After switching, the layout fee is also discounted by 20%. It has been 10 days since the switch, and there is no news yet. But no news is the best news, right?(0) 讚! | 熙恩mm |
作者: Daley 領域: 医学 審稿時間: 4.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-10 15:46:04 評論於 It is very likely that there will be a higher IF for this journal this year, so I submitted one my dissertation chapters in hopes that it gets published. (0) 讚! | Daley |
作者: 墟散高芬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-10-10 11:20:43 評論於 Review speed: 3.0 Experience sharing: There is a high possibility of a higher IF this year, so I tried submitting a paper and hope to receive a response(0) 讚! | 墟散高芬 |
作者: Boyd DeQuincey 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2016-08-30 12:05:11 評論於 How about doing a clinical study on blood? What is the acceptance rate among Chinese people? Seeking guidance from experts(0) 讚! | Boyd DeQuincey |
作者: Viola Orlando 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-09-21 14:43:05 評論於 Review speed: 1.0 | Submission acceptance rate: 25.0 Experience sharing: They have a rapid in-house review process, the internal review is very fast, and they received a rejection letter within 3 days of submission, without even sending it for external review (crying(0) 讚! | Viola Orlando |
作者: 深渊辰君 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2014-06-06 11:35:05 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: The speed is very fast. I submitted on June 4th and received a reply on June 6th stating, "Our final decision is that your contribution is not acceptable for publication in the American Journal of Hematology. We very much regret having to make a negative decision on this manuscript. You will appreciate the fact that AJH has an overall acceptance rate of _."(0) 讚! | 深渊辰君 |
作者: Moore Simpson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-11-06 22:55:05 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: The review speed is very fast. The submission was made on Monday and got rejected on Wednesday. The rejection letter mentioned: "You will appreciate the fact that AJH has an overall acceptance rate of < 25%." Although it was rejected, I feel that this journal is still very efficient. I will try again in the future(0) 讚! | Moore Simpson |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-26 09:56:51 評論於 Review speed: 1.0 | Submission hit rate: 25.0 Experience sharing: Rejected 4 days after review. The rejection letter mentioned: You will appreciate the fact that AJH has an overall acceptance rate of(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-22 15:47:00 評論於 Editorial speed: 1.0 | Submission acceptance rate: 50.0 Experience sharing: The submission status changed to "Evaluating Recommendation" on the same day of submission, which means the Associate Editor has directly submitted it to the Editor-in-Chief for a decision. I am still waiting for the review results, and will provide further updates later(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 2 下一頁 末頁 (頁 |
Contact us